JACOBS LEVY EQUITY MANAGEMENT, INC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2021$2,300,000
-25.9%
756,675
+70.8%
0.02%
-28.6%
Q3 2021$3,106,000
+87.0%
443,081
+144.9%
0.02%
+90.9%
Q2 2021$1,661,000
-2.2%
180,944
+3.6%
0.01%
-15.4%
Q1 2021$1,698,000
+59.9%
174,693
+68.7%
0.01%
+44.4%
Q4 2020$1,062,000
+0.7%
103,528
-1.0%
0.01%
-18.2%
Q3 2020$1,055,000
-7.0%
104,543
-3.8%
0.01%
-8.3%
Q2 2020$1,134,000
+61.1%
108,689
+30.3%
0.01%
+33.3%
Q1 2020$704,000
-36.2%
83,445
-33.9%
0.01%
-18.2%
Q4 2019$1,104,000
-2.1%
126,175
+20.4%
0.01%
-21.4%
Q3 2019$1,128,000
+131.1%
104,820
+173.3%
0.01%
+100.0%
Q2 2019$488,000
-71.1%
38,360
-12.0%
0.01%
-70.8%
Q1 2019$1,690,000
+373.4%
43,580
+148.5%
0.02%
+300.0%
Q4 2018$357,000
+49.4%
17,540
+236.7%
0.01%
+100.0%
Q3 2018$239,000
-66.9%
5,210
-28.6%
0.00%
-76.9%
Q4 2017$721,0007,2970.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 2,400,000$25,032,0001.43%
TANG CAPITAL MANAGEMENT LLC 1,365,376$14,241,0001.38%
Palo Alto Investors LP 1,343,897$14,017,0000.84%
Sofinnova Investments, Inc. 1,197,630$12,491,0000.79%
Gyon Technologies Capital Management, LP 29,745$310,0000.75%
RICE HALL JAMES & ASSOCIATES, LLC 455,567$4,752,0000.20%
GLOBEFLEX CAPITAL L P 63,226$659,0000.17%
PDT Partners, LLC 188,538$1,966,0000.13%
CADENCE CAPITAL MANAGEMENT LLC 71,179$742,0000.11%
FRED ALGER MANAGEMENT, LLC 2,474,029$25,804,0000.08%
View complete list of PUMA BIOTECHNOLOGY INC shareholders